Traded Jul 6 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Traded Jun 17, 2026 · Filed Jun 17, 2026
Hims & Hers Health's CTO sold $946K of Hims & Hers Health shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$946,260
Shares × reported transaction price
37 days after results of May 11, 2026, 54 days before results of Aug 10, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.8% | −1.7% | −6.1% |
| 30 days | −7.8% | −0.6% | −7.2% |
| 90 days | −21.1% | +1.0% | −22.0% |
Past results only. Not a forecast.
Traded Jul 6 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.
Oluyemi Okupe (Chief Financial Officer) sold ~$261K of Hims & Hers Health
Scheduled in advanceTraded Jul 6 · filed 1 day later
Derivative exercise or conversion — not an open-market buy.